Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.0
7.8
Journals
Vaccines
Special Issues
50 Years of Immunization—Steps Forward
share announcement

50 Years of Immunization—Steps Forward

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: 31 October 2024 | Viewed by 1663

Special Issue Editors

Dr. Imran Raza Mirza

E-Mail Website
Guest Editor
UNICEF, New York, NY 10017, USA
Interests: child and maternal health
Special Issues, Collections and Topics in MDPI journals
Dr. Ephrem Tekle Lemango

E-Mail Website
Guest Editor
UNICEF, New York, NY 10017, USA
Interests: immunization
Dr. Ann Lindstrand

E-Mail Website
Guest Editor
WHO, 1211 Geneva, Switzerland
Interests: immunization

Special Issue Information

Dear Colleagues,

The Expanded Program on Immunization (EPI) was launched to ensure that all children worldwide could have access to vaccines in 1974. The program aimed to provide vaccines for six diseases—diphtheria, pertussis, tetanus, poliomyelitis, measles, and tuberculosis—to every child globally by 1990. Today, every country has a national immunization program, frequently named the essential program on immunization. The program's scope has expanded to include vaccinations for older children, adolescents, and adults, with the World Health Organization (WHO) recommending 13 vaccines. Throughout its history, EPI has contributed to innovations in supply chain management, digital technologies, monitoring systems, safety surveillance, and injection techniques. EPI continues to work in synergy with other public health programs to control infectious diseases and achieve better health for all populations worldwide.

In 2024, it will be 50 years since the inception of EPI; therefore, we invite you to submit your original manuscripts, reviews, position papers, opinion papers, perspective papers, and case studies on vaccine-related topics such as program implementation, research, and vaccination-related policies. We also welcome submissions exploring vaccination in diverse and marginalized communities and communities in humanitarian crises. We also welcome submissions on lessons learned from past and present health crises and their implications for pandemic preparedness in the future. We look forward to receiving your contributions.

Dr. Imran Raza Mirza
Dr. Ephrem Tekle Lemango
Dr. Ann Lindstrand
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccines
  • immunization
  • outbreaks
  • humanitarian crises

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

12 pages, 238 KiB  
Article
COVID-19 Vaccine Hesitancy and Associated Oral Cholera Vaccine Hesitancy in a Cholera-Endemic Country: A Community-Based Cross-Sectional Study in the Democratic Republic of Congo
by Arsene Daniel Nyalundja, Patrick Musole Bugeme, Alain Balola Ntaboba, Victoire Urbain Hatu’m, Guillaume Shamamba Ashuza, Jacques Lukenze Tamuzi, Duduzile Ndwandwe, Chinwe Iwu-Jaja, Charles Shey Wiysonge and Patrick D. M. C. Katoto
Vaccines 2024, 12(4), 444; https://doi.org/10.3390/vaccines12040444 - 22 Apr 2024
Viewed by 588
Abstract
COVID-19 vaccine hesitancy and its enablers shape community uptake of non-covid vaccines such as the oral cholera vaccine (OCV) in the post-COVID-19 era. This study assessed the impact of COVID-19 vaccine hesitancy and its drivers on OCV hesitancy in a cholera-endemic region of [...] Read more.
COVID-19 vaccine hesitancy and its enablers shape community uptake of non-covid vaccines such as the oral cholera vaccine (OCV) in the post-COVID-19 era. This study assessed the impact of COVID-19 vaccine hesitancy and its drivers on OCV hesitancy in a cholera-endemic region of the Democratic Republic of Congo. We conducted a community-based survey in Bukavu. The survey included demographics, intention to take OCV and COVID-19 vaccines, reasons for COVID-19 hesitancy, and thoughts and feelings about COVID-19 vaccines. Poisson regression analyses were performed. Of the 1708 respondents, 84.66% and 77.57% were hesitant to OCV alone and to both OCV and COVID-19, respectively. Hesitancy to COVID-19 vaccines rose OCV hesitancy by 12% (crude prevalence ratio, [cPR] = 1.12, 95%CI [1.03–1.21]). Independent predictors of OCV hesitancy were living in a semi-urban area (adjusted prevalence ratio [aPR] = 1.10, 95%CI [1.03–1.12]), religious refusal of vaccines (aPR = 1.06, 95%CI [1.02–1.12]), concerns about vaccine safety (aPR = 1.05, 95%CI [1.01–1.11]) and adverse effects (aPR = 1.06, 95%CI [1.01–1.12]), as well as poor vaccine literacy (aPR = 1.07, 95%CI [1.01–1.14]). Interestingly, the belief in COVID-19 vaccine effectiveness reduced OCV hesitancy by 24% (aPR = 0.76, 95%CI [0.62–0.93]). COVID-19 vaccine hesitancy and its drivers exhibited a significant domino effect on OCV uptake. Addressing vaccine hesitancy through community-based health literacy and trust-building interventions would likely improve the introduction of novel non-COVID-19 vaccines in the post-COVID-19 era. Full article
(This article belongs to the Special Issue 50 Years of Immunization—Steps Forward)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop